George Matcham
Director/Board Member at INSTIL BIO, INC.
Net worth: 419 269 $ as of 2024-05-30
George Matcham active positions
| Companies | Position | Start | End |
|---|---|---|---|
| INSTIL BIO, INC. | Director/Board Member | 2018-08-31 | - |
| Independent Dir/Board Member | 2018-08-31 | - |
Career history of George Matcham
Former positions of George Matcham
| Companies | Position | Start | End |
|---|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Director/Board Member | 2021-07-04 | 2023-08-02 |
| CELGENE | Corporate Officer/Principal | 2013-04-30 | 2018-05-31 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Chief Operating Officer | - | - |
Training of George Matcham
| University of Cardiff | Doctorate Degree |
| University of Cambridge | Graduate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 3 |
| Australia | 2 |
Operational
| Director/Board Member | 2 |
| Independent Dir/Board Member | 1 |
| Chief Operating Officer | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Private companies | 2 |
|---|---|
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
- Stock Market
- Insiders
- George Matcham
- Experience
